|
Enfuvirtide,an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America Lalezari JP, et al.
New England Journal of Medicine
Published at http://www.nejm.org March 13, 2003
Link The addition of enfuvirtide to an optimized antiretroviral regimen provided significant antiretroviral and immunologic benefit through 24 weeks in patients who had previously received multiple antiretroviral drugs and had multidrug-resistant HIV-1 infection. (prevention)
—Posted: March 14, 2003
More journal headlines: This month | Last month | Search archive
|
